What Nitrofurantoin Cures
Nitrofurantoin is specifically indicated for the treatment of uncomplicated lower urinary tract infections (cystitis) caused by susceptible bacteria, and it is recommended as a first-line agent for this indication. 1, 2
Primary Indication: Uncomplicated Cystitis
Nitrofurantoin is the drug of choice for uncomplicated cystitis in women based on robust evidence of efficacy and its ability to spare more systemically active agents for other infections 1. Current guidelines position it as first-line therapy with a 5-day treatment course at 100 mg twice daily 1, 2.
Organisms Treated
Nitrofurantoin effectively treats UTIs caused by:
- Escherichia coli (most common uropathogen)
- Klebsiella species
- Enterobacter species
- Enterococcus species
- Staphylococcus saprophyticus
- Staphylococcus aureus
Additional Uses
Recurrent UTI Prevention
Nitrofurantoin is effective for prophylaxis in patients with recurrent urinary tract infections, maintaining excellent activity against common uropathogens despite decades of use 5, 6.
Catheter-Associated Bacteriuria Suppression
The drug can be used to suppress catheter-associated bacteria, though evidence for treatment duration in catheter-associated UTI remains insufficient 1, 5.
Critical Limitations: What Nitrofurantoin Does NOT Cure
Nitrofurantoin should NOT be used for:
- Pyelonephritis or upper urinary tract infections - The drug does not achieve therapeutic blood or tissue concentrations 7, 8
- Systemic infections or bacteremia - Serum levels are inadequate for treating bloodstream infections 8
- Complicated UTIs with systemic involvement - Limited tissue penetration makes it inappropriate 1
- Prostatitis - Poor prostatic tissue penetration 8
Important Prescribing Caveats
Absolute Contraindications (per FDA labeling):
- Renal impairment (creatinine clearance <60 mL/min or clinically significant elevated serum creatinine) - inadequate urinary concentrations and increased toxicity risk 7
- Last trimester of pregnancy - risk of hemolytic anemia in newborns 2
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency - risk of severe hemolytic anemia 7
Serious Adverse Effects Requiring Monitoring:
- Pulmonary reactions (acute, subacute, chronic) - can be fatal, especially with therapy >6 months 7
- Hepatotoxicity - including hepatic necrosis with fatalities reported 7
- Peripheral neuropathy - may be severe or irreversible, particularly in patients with renal impairment, anemia, diabetes, or vitamin B deficiency 7
Why Nitrofurantoin Remains First-Line
Despite being available for over 60 years, nitrofurantoin maintains excellent activity against uropathogens with minimal resistance development 4, 6. Its unique advantage is minimal collateral damage to gut and other body microbiomes due to high urinary concentration but low serum/tissue levels 6. This site-specific action preserves the body's microbial homeostasis while effectively treating bladder infections.
The drug interferes with multiple bacterial cellular functions simultaneously, making resistance development uncommon 3, 9. Recent meta-analyses confirm nitrofurantoin is noninferior to other commonly prescribed antibiotics for UTI treatment, and may be superior to single-dose fosfomycin 6.